Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM)
Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update
Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston
Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise
Aspira Women's Health Appoints New Chief Financial Officer
Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update
Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors
Aspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New Patients
Aspira Announces First Quarter 2025 Financial Results and Provides Business Update
Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"
Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq
Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement
Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award
Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results
Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors